Mainz Biomed B.V. (MYNZ)
NASDAQ: MYNZ · IEX Real-Time Price · USD
0.349
-0.031 (-8.16%)
At close: Jul 19, 2024, 4:00 PM
0.359
+0.010 (2.75%)
Pre-market: Jul 22, 2024, 7:33 AM EDT
Mainz Biomed B.V. Stock Forecast
MYNZ's stock price has decreased by -92.49% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 1 analyst with a 12-month price forecast for Mainz Biomed B.V. stock has a target of 3.00, which predicts an increase of 759.60% from the current stock price of 0.35.
Analyst Consensus: Buy
* Price targets were last updated on Mar 6, 2024.
Analyst Ratings
The average analyst rating for MYNZ stock from 2 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 | Jul '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 1 | 1 | 1 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Cantor Fitzgerald | Cantor Fitzgerald | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Apr 12, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $5 → $3 | Strong Buy | Maintains | $5 → $3 | +759.60% | Mar 6, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Nov 21, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $9 → $5 | Strong Buy | Maintains | $9 → $5 | +1,332.66% | Nov 20, 2023 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $9 | Buy | Reiterates | $9 | +2,478.80% | Sep 26, 2023 |
Financial Forecast
Revenue This Year
1.50M
from 895.48K
Increased by 67.40%
Revenue Next Year
4.36M
from 1.50M
Increased by 191.13%
EPS This Year
-0.81
from -1.62
EPS Next Year
-0.65
from -0.81
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 2.1M | 6.6M | 17.6M | 47.0M | 108.7M |
| Avg | 1.5M | 4.4M | 13.2M | 45.7M | 105.6M |
| Low | 1.1M | 2.3M | 9.0M | 43.9M | 101.5M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 135.5% | 338.2% | 303.6% | 255.2% | 137.9% |
| Avg | 67.4% | 191.1% | 203.5% | 245.0% | 131.1% |
| Low | 20.4% | 50.4% | 106.6% | 231.5% | 122.0% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -0.67 | -0.56 | -0.44 | -0.33 | -0.04 |
| Avg | -0.81 | -0.65 | -0.55 | -0.32 | -0.04 |
| Low | -0.89 | -0.73 | -0.64 | -0.30 | -0.04 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | - |
| Avg | - | - | - | - | - |
| Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.